Hyundai Motor America is expanding support for COVID-19 drive-thru testing to 22 hospitals across the US with US$4m in grants through its Hope On Wheels programme. These grants are designed to combat the coronavirus by providing increased access to testing throughout the nation.
The company also announced a donation of 65,000 COVID-19 RT-PCR tests developed by Seegene, a South Korea-based specialist in multiplex molecular diagnostics.
Go deeper with GlobalData
Seegene’s test can simultaneously detect three different genes (N, E and RdRP) of SARS-CoV-2, the virus responsible for COVID-19.
Hyundai claims to be the only automaker providing these testing capabilities to hospitals, especially in hard-hit cities like New Orleans, Chicago and Detroit.
Jose Munoz, president and CEO of Hyundai Motor North America, said: “A best practice that was crucial in South Korea’s handling of the coronavirus was drive-thru testing. This approach protects the healthcare workers and patients from the potential spread of the virus while diagnosing those most in need.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
